The Pharmaceutical Care Management Association (PCMA), the national trade association representing America’s pharmacy benefit managers, has named JC Scott the association’s next President and CEO, effective October 15. Scott is currently the Chief Advocacy Officer for the Advanced Medical Technology
(Washington, D.C.) — Pharmaceutical Care Management Association President and CEO Mark Merritt issued the following statement on the Administration’s announcement to provide Medicare Part D plans additional flexibility in designing Medicare Part D formularies around medical indications. “While PCMA is
Jonathan Buxton Senior Director, State Affairs Jonathan Buxton is Senior Director, State Affairs for PCMA. In this role he serves as a fierce advocate for member companies and works to educate legislators and regulators on the value PBMs bring to
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) has filed a motion for summary judgment to vacate the effective date of the Trump Administration’s rebate rule. The motion for summary judgment, filed in the U.S. District Court for the
Pharmacy benefit managers (PBMs) are using the availability of alternatives, both biosimilars and their reference biologics, as part of an overall strategy to remove costs from the health care system. This direct competition, in turn, lowers patients’ costs.
©2024 PCMA. All Rights Reserved.
